| 摘要 |
<p>The present invention provides beta3-adrenergic receptor agonists of structural Formula (I) as well as pharmaceutical formulations thereof and methods for treating beta3-adrenergic receptor-mediated diseases, conditions, or disorders using such compounds.</p> |
